Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Gait disturbance, Inappropriate schedule of product administration
Clinical narrative: he passed away on Dec 17 2021 with continued symptoms of breathing difficulties/not be able to breath; He could not walk the distance of the halls of the house; he passed away; Received first Modena vaccine on Jan 28, 2021 and second COVID vaccine on March 05, 2021; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (he passed away) and DYSPNOEA (he passed away on Dec 17 2021 with continued symptoms of breathing difficulties/not be able to breath) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Low pulse rate in 2015, Hospitalization from 24-Feb-2021 to 02-Mar-2021, Thrombosis leg, Thrombosis pulmonary, Lung opacity, Dyspnoea and Pacemaker insertion (cardiac) (pacemaker prior to vaccination). Previously administered products included for Drug use for unknown indication: Flu shot (Flu shot in 2020 (Sept/Oct)) in 2020. Past adverse reactions to the above products included No adverse event with Flu shot. Concurrent medical conditions included Seasonal allergy. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), PREDNISONE, APIXABAN (ELIQUIS) and OMEPRAZOLE for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first Modena vaccine on Jan 28, 2021 and second COVID vaccine on March 05, 2021). On an unknown date, the patient experienced DYSPNOEA (he passed away on Dec 17 2021 with continued symptoms of breathing difficulties/not be able to breath) (seriousness criterion medically significant) and GAIT DISTURBANCE (He could not walk the distance of the halls of the house). The patient died on 17-Dec-2021. The cause of death was not reported. It is unknown if an autopsy was performed. At the time of death, DYSPNOEA (he passed away on Dec 17 2021 with continued symptoms of breathing difficulties/not be able to breath) had not resolved and GAIT DISTURBANCE (He could not walk the distance of the halls of the house) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first Modena vaccine on Jan 28, 2021 and second COVID vaccine on March 05, 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No history of blood clots and no consistent medical problems until the vaccination. He was able to do most anything that he wanted to do and no history of COVID.Concomitants medications includes water pill. For concomitant medication Eliquis reporter was unsure if taking at the time.It was reported that at the encouragement of his family doctor he received a second COVID vaccine. He did not get a booster and a third one. Patient placed on a blood thinner in Feb- 2021 and remained on it until time of death.Received Modena vaccine on Jan 28, 2021.Went to PCP on Feb 24, 2021 first for breathing difficulties, they sent him to the hospital.Admitted to hospital on Feb 24 2021. They found blood clots in legs and lungs. Caller states hospital said patients lungs looked like chards of glass. Caller states her husband had no history of blood clots. He continued to have problems with breathing that they(HCPs) felt could have been a clot interfering with his breathing. Dischar March 02, 2021. CC This spontaneous fatal case concerns a 75-year-old male patient, with medical history of hospitalization because of blood clots in legs and lungs, dyspnea and lung opacity approximately 9 months prior to death (and 28 days after receiving the first dose of mRNA-1273 vaccine), dyspnea remaining after hospitalization, and Pacemaker insertion prior to vaccination, who experienced the unexpected serious events of DEATH and dyspnoea. Death occurred approximately 9 months and 12 days after receiving second dose of mRNA-1273 vaccine. Patient passed away on Dec 17 2021 with continued symptoms of breathing difficulties. He could not walk the distance of the halls of the house and be able to breath. The cause of death was not reported. It is unknown if an autopsy was performed. The mentioned medical history remains as a confounder. INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION was considered as an additional event. The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2022-494173 (Patient Link).; Sender's Comments: This spontaneous fatal case concerns a 75-year-old male patient, with medical history of hospitalization because of blood clots in legs and lungs, dyspnea and lung opacity approximately 9 months prior to death (and 28 days after receiving the first dose of mRNA-1273 vaccine), dyspnea remaining after hospitalization, and Pacemaker insertion prior to vaccination, who experienced the unexpected serious events of DEATH and dyspnoea. Death occurred approximately 9 months and 12 days after receiving second dose of mRNA-1273 vaccine. Patient passed away on Dec 17 2021 with continued symptoms of breathing difficulties. He could not walk the distance of the halls of the house and be able to breath. The cause of death was not reported. It is unknown if an autopsy was performed. The mentioned medical history remains as a confounder. INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION was considered as an additional event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Reported Cause(s) of Death: he passed away